| Application no. and date | 16827318.3 (espacenet) (Federated) (European Patent Register), 20160721 | | Patent/reg. no. and date | DK/EP 3324968, 20230927 | | Publication date | 20180530 | | Priority no. and date | US 201562195243 P, 20150721 | | EP pub. no. and date |
EP 3324968 20180530 | | Effective date | | | Applicant/owner | Athenex Therapeutics Limited, 11/F Axa Center
Gloucester Road, 151
Hong Kong, CN | | Applicant ref. no. | | | Inventor | KWAN, Min-fun, Rudolf, 9 Friar Tuck Circle
Summit, NJ 07901, US,
KRAMER, E., Douglas, 71 Kensington Road
Stamford, CT 06905, US,
FETTERLY, Geralk, J., 44 Huntwood Court
Getezville, NY 14068, US,
HUNG, Cheung-tak, 88 Campbells Road
Pine Hill
Dunedin 9010, NZ,
JACKSON, Christopher Glyn Charles, Alexander, 83 Norfolk Street
St Clair
Dunedin 9012, NZ,
GLUE, Paul, William, Department Of Psychological Medicine
University Of Otago
Po Box 56
Dunedin 9054, NZ | | Representative | | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/4725 (2006.01) , A61K 31/475 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER | | Int. application no. | IB2016001132 | | Int. publication no. | WO2017013490 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
